In separated studies, the high activity of JNK favored tumor initiation, metastasis and was linked to poor clinical outcome in mammary tumors in vivo [255], as well as it drove TNBC tumorigenesis by promoting cancer stem-like cell (CSC) phenotype through the Notch1 signaling pathway [256]. This evidence concerns the gene MAPK8 and neoplasm.